Healthcare -
Biotechnology - NASDAQ - US
$ 1.93
-1.64 %
$ 644 M
Market Cap
-1.48
P/E
IOVA - LONG-TERM DEBT
Long-term Debt IOVA - Iovance Biotherapeutics, Inc.
45.4 M
LAST VALUE
-21.09%
2 YEAR CAGR
39.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR